[HTML][HTML] Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - BMC cancer, 2012 - Springer
Background Advanced ovarian cancer is treated with cytoreductive surgery and combination
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche… - BMC …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Advanced ovarian cancer is treated with cytoreductive surgery and combination
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - BMC Cancer, 2012 - europepmc.org
Background Advanced ovarian cancer is treated with cytoreductive surgery and combination
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
[PDF][PDF] Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - 2012 - core.ac.uk
Background: Advanced ovarian cancer is treated with cytoreductive surgery and
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
[HTML][HTML] Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
AA Goyeneche, CM Telleria - BMC Cancer, 2012 - ncbi.nlm.nih.gov
Background Advanced ovarian cancer is treated with cytoreductive surgery and combination
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - 2012 - search.ebscohost.com
The article presents the findings of a research conducted on examining whether
mifepristone helps in preventing repopulation of ovarian cancer cells escaping cisplatin …
mifepristone helps in preventing repopulation of ovarian cancer cells escaping cisplatin …
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - BMC Cancer, 2012 - go.gale.com
Background Advanced ovarian cancer is treated with cytoreductive surgery and combination
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
platinum-and taxane-based chemotherapy. Although most patients have acute clinical …
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra Luques, AA Goyeneche… - 2012 - datosdeinvestigacion.conicet.gov.ar
Background: Advanced ovarian cancer is treated with cytoreductive surgery and
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
[PDF][PDF] Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche, MB Hapon… - 2012 - cyberleninka.org
Background: Advanced ovarian cancer is treated with cytoreductive surgery and
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
combination platinum-and taxane-based chemotherapy. Although most patients have acute …
[HTML][HTML] Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
CD Gamarra-Luques, AA Goyeneche… - BMC …, 2012 - bmccancer.biomedcentral.com
Advanced ovarian cancer is treated with cytoreductive surgery and combination platinum-
and taxane-based chemotherapy. Although most patients have acute clinical response to …
and taxane-based chemotherapy. Although most patients have acute clinical response to …